HEADER LIPASE 08-FEB-95 1CLE TITLE STRUCTURE OF UNCOMPLEXED AND LINOLEATE-BOUND CANDIDA CYLINDRACEA TITLE 2 CHOLESTEROL ESTERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLESTEROL ESTERASE; COMPND 3 CHAIN: A, B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA CYLINDRACEA; SOURCE 3 ORGANISM_TAXID: 44322 KEYWDS ESTERASE, SUBSTRATE/PRODUCT-BOUND, LIPASE EXPDTA X-RAY DIFFRACTION AUTHOR D.GHOSH REVDAT 5 23-OCT-24 1CLE 1 HETSYN REVDAT 4 29-JUL-20 1CLE 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 1CLE 1 VERSN REVDAT 2 24-FEB-09 1CLE 1 VERSN REVDAT 1 08-MAR-96 1CLE 0 JRNL AUTH D.GHOSH,Z.WAWRZAK,V.Z.PLETNEV,N.LI,R.KAISER,W.PANGBORN, JRNL AUTH 2 H.JORNVALL,M.ERMAN,W.L.DUAX JRNL TITL STRUCTURE OF UNCOMPLEXED AND LINOLEATE-BOUND CANDIDA JRNL TITL 2 CYLINDRACEA CHOLESTEROL ESTERASE. JRNL REF STRUCTURE V. 3 279 1995 JRNL REFN ISSN 0969-2126 JRNL PMID 7788294 JRNL DOI 10.1016/S0969-2126(01)00158-7 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.KAISER,M.ERMAN,W.L.DUAX,D.GHOSH,H.JORNVALL REMARK 1 TITL MONOMERIC AND DIMERIC FORMS OF CHOLESTEROL ESTERASE FROM REMARK 1 TITL 2 CANDIDA CYLINDRACEA: PRIMARY STRUCTURE, IDENTITY IN PEPTIDE REMARK 1 TITL 3 PATTERNS, AND ADDITIONAL MICROHETEROGENEITY REMARK 1 REF FEBS LETT. V. 337 123 1994 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.GHOSH,M.ERMAN,W.L.DUAX REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY DIFFRACTION ANALYSIS OF REMARK 1 TITL 2 CHOLESTEROL ESTERASE FROM CANDIDA CYLINDRACEA REMARK 1 REF J.STEROID BIOCHEM.MOL.BIOL. V. 38 663 1991 REMARK 1 REFN ISSN 0960-0760 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 54351 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8072 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 188 REMARK 3 SOLVENT ATOMS : 478 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.560 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.390 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CLE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172371. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 1993 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : RIGAKU REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 119382 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 18 -60.15 70.81 REMARK 500 PHE A 38 -1.65 62.93 REMARK 500 ALA A 159 -145.37 51.66 REMARK 500 ALA A 165 -151.82 -124.41 REMARK 500 SER A 209 -118.97 64.57 REMARK 500 SER A 241 88.12 70.00 REMARK 500 ALA A 243 -109.81 -137.71 REMARK 500 SER A 301 -124.41 47.93 REMARK 500 ASP A 318 118.89 -37.05 REMARK 500 ASP A 340 58.03 -113.01 REMARK 500 LEU A 350 1.73 -67.23 REMARK 500 ASP A 384 107.23 -36.60 REMARK 500 PHE A 415 -58.52 -126.36 REMARK 500 ILE A 444 -48.02 66.22 REMARK 500 ALA A 450 -0.78 80.72 REMARK 500 ASN A 468 -77.52 -108.83 REMARK 500 SER A 498 -76.29 -46.44 REMARK 500 ILE B 18 -58.18 70.39 REMARK 500 ALA B 159 -137.71 60.32 REMARK 500 ALA B 165 -158.45 -124.43 REMARK 500 SER B 209 -120.52 61.35 REMARK 500 SER B 241 78.33 66.89 REMARK 500 ALA B 243 -122.38 -136.00 REMARK 500 SER B 301 -127.96 50.41 REMARK 500 LYS B 313 -66.06 -126.30 REMARK 500 ASP B 340 59.51 -113.45 REMARK 500 ASP B 384 106.49 -34.40 REMARK 500 PHE B 415 -64.93 -127.75 REMARK 500 ILE B 444 -43.99 71.60 REMARK 500 ASN B 468 -78.77 -113.00 REMARK 500 ASP B 515 57.48 -95.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD IN CHAIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: CAB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD IN CHAIN B DBREF 1CLE A 1 534 UNP P32947 LIP3_CANRU 16 549 DBREF 1CLE B 1 534 UNP P32947 LIP3_CANRU 16 549 SEQADV 1CLE VAL A 344 UNP P32947 ILE 359 CONFLICT SEQADV 1CLE VAL B 344 UNP P32947 ILE 359 CONFLICT SEQRES 1 A 534 ALA PRO THR ALA LYS LEU ALA ASN GLY ASP THR ILE THR SEQRES 2 A 534 GLY LEU ASN ALA ILE ILE ASN GLU ALA PHE LEU GLY ILE SEQRES 3 A 534 PRO PHE ALA GLU PRO PRO VAL GLY ASN LEU ARG PHE LYS SEQRES 4 A 534 ASP PRO VAL PRO TYR SER GLY SER LEU ASN GLY GLN LYS SEQRES 5 A 534 PHE THR SER TYR GLY PRO SER CYS MET GLN GLN ASN PRO SEQRES 6 A 534 GLU GLY THR PHE GLU GLU ASN LEU GLY LYS THR ALA LEU SEQRES 7 A 534 ASP LEU VAL MET GLN SER LYS VAL PHE GLN ALA VAL LEU SEQRES 8 A 534 PRO GLN SER GLU ASP CYS LEU THR ILE ASN VAL VAL ARG SEQRES 9 A 534 PRO PRO GLY THR LYS ALA GLY ALA ASN LEU PRO VAL MET SEQRES 10 A 534 LEU TRP ILE PHE GLY GLY GLY PHE GLU ILE GLY SER PRO SEQRES 11 A 534 THR ILE PHE PRO PRO ALA GLN MET VAL THR LYS SER VAL SEQRES 12 A 534 LEU MET GLY LYS PRO ILE ILE HIS VAL ALA VAL ASN TYR SEQRES 13 A 534 ARG VAL ALA SER TRP GLY PHE LEU ALA GLY ASP ASP ILE SEQRES 14 A 534 LYS ALA GLU GLY SER GLY ASN ALA GLY LEU LYS ASP GLN SEQRES 15 A 534 ARG LEU GLY MET GLN TRP VAL ALA ASP ASN ILE ALA GLY SEQRES 16 A 534 PHE GLY GLY ASP PRO SER LYS VAL THR ILE PHE GLY GLU SEQRES 17 A 534 SER ALA GLY SER MET SER VAL LEU CYS HIS LEU ILE TRP SEQRES 18 A 534 ASN ASP GLY ASP ASN THR TYR LYS GLY LYS PRO LEU PHE SEQRES 19 A 534 ARG ALA GLY ILE MET GLN SER GLY ALA MET VAL PRO SER SEQRES 20 A 534 ASP PRO VAL ASP GLY THR TYR GLY ASN GLU ILE TYR ASP SEQRES 21 A 534 LEU PHE VAL SER SER ALA GLY CYS GLY SER ALA SER ASP SEQRES 22 A 534 LYS LEU ALA CYS LEU ARG SER ALA SER SER ASP THR LEU SEQRES 23 A 534 LEU ASP ALA THR ASN ASN THR PRO GLY PHE LEU ALA TYR SEQRES 24 A 534 SER SER LEU ARG LEU SER TYR LEU PRO ARG PRO ASP GLY SEQRES 25 A 534 LYS ASN ILE THR ASP ASP MET TYR LYS LEU VAL ARG ASP SEQRES 26 A 534 GLY LYS TYR ALA SER VAL PRO VAL ILE ILE GLY ASP GLN SEQRES 27 A 534 ASN ASP GLU GLY THR VAL PHE GLY LEU SER SER LEU ASN SEQRES 28 A 534 VAL THR THR ASN ALA GLN ALA ARG ALA TYR PHE LYS GLN SEQRES 29 A 534 SER PHE ILE HIS ALA SER ASP ALA GLU ILE ASP THR LEU SEQRES 30 A 534 MET ALA ALA TYR PRO GLN ASP ILE THR GLN GLY SER PRO SEQRES 31 A 534 PHE ASP THR GLY ILE PHE ASN ALA ILE THR PRO GLN PHE SEQRES 32 A 534 LYS ARG ILE SER ALA VAL LEU GLY ASP LEU ALA PHE ILE SEQRES 33 A 534 HIS ALA ARG ARG TYR PHE LEU ASN HIS PHE GLN GLY GLY SEQRES 34 A 534 THR LYS TYR SER PHE LEU SER LYS GLN LEU SER GLY LEU SEQRES 35 A 534 PRO ILE MET GLY THR PHE HIS ALA ASN ASP ILE VAL TRP SEQRES 36 A 534 GLN ASP TYR LEU LEU GLY SER GLY SER VAL ILE TYR ASN SEQRES 37 A 534 ASN ALA PHE ILE ALA PHE ALA THR ASP LEU ASP PRO ASN SEQRES 38 A 534 THR ALA GLY LEU LEU VAL ASN TRP PRO LYS TYR THR SER SEQRES 39 A 534 SER SER GLN SER GLY ASN ASN LEU MET MET ILE ASN ALA SEQRES 40 A 534 LEU GLY LEU TYR THR GLY LYS ASP ASN PHE ARG THR ALA SEQRES 41 A 534 GLY TYR ASP ALA LEU MET THR ASN PRO SER SER PHE PHE SEQRES 42 A 534 VAL SEQRES 1 B 534 ALA PRO THR ALA LYS LEU ALA ASN GLY ASP THR ILE THR SEQRES 2 B 534 GLY LEU ASN ALA ILE ILE ASN GLU ALA PHE LEU GLY ILE SEQRES 3 B 534 PRO PHE ALA GLU PRO PRO VAL GLY ASN LEU ARG PHE LYS SEQRES 4 B 534 ASP PRO VAL PRO TYR SER GLY SER LEU ASN GLY GLN LYS SEQRES 5 B 534 PHE THR SER TYR GLY PRO SER CYS MET GLN GLN ASN PRO SEQRES 6 B 534 GLU GLY THR PHE GLU GLU ASN LEU GLY LYS THR ALA LEU SEQRES 7 B 534 ASP LEU VAL MET GLN SER LYS VAL PHE GLN ALA VAL LEU SEQRES 8 B 534 PRO GLN SER GLU ASP CYS LEU THR ILE ASN VAL VAL ARG SEQRES 9 B 534 PRO PRO GLY THR LYS ALA GLY ALA ASN LEU PRO VAL MET SEQRES 10 B 534 LEU TRP ILE PHE GLY GLY GLY PHE GLU ILE GLY SER PRO SEQRES 11 B 534 THR ILE PHE PRO PRO ALA GLN MET VAL THR LYS SER VAL SEQRES 12 B 534 LEU MET GLY LYS PRO ILE ILE HIS VAL ALA VAL ASN TYR SEQRES 13 B 534 ARG VAL ALA SER TRP GLY PHE LEU ALA GLY ASP ASP ILE SEQRES 14 B 534 LYS ALA GLU GLY SER GLY ASN ALA GLY LEU LYS ASP GLN SEQRES 15 B 534 ARG LEU GLY MET GLN TRP VAL ALA ASP ASN ILE ALA GLY SEQRES 16 B 534 PHE GLY GLY ASP PRO SER LYS VAL THR ILE PHE GLY GLU SEQRES 17 B 534 SER ALA GLY SER MET SER VAL LEU CYS HIS LEU ILE TRP SEQRES 18 B 534 ASN ASP GLY ASP ASN THR TYR LYS GLY LYS PRO LEU PHE SEQRES 19 B 534 ARG ALA GLY ILE MET GLN SER GLY ALA MET VAL PRO SER SEQRES 20 B 534 ASP PRO VAL ASP GLY THR TYR GLY ASN GLU ILE TYR ASP SEQRES 21 B 534 LEU PHE VAL SER SER ALA GLY CYS GLY SER ALA SER ASP SEQRES 22 B 534 LYS LEU ALA CYS LEU ARG SER ALA SER SER ASP THR LEU SEQRES 23 B 534 LEU ASP ALA THR ASN ASN THR PRO GLY PHE LEU ALA TYR SEQRES 24 B 534 SER SER LEU ARG LEU SER TYR LEU PRO ARG PRO ASP GLY SEQRES 25 B 534 LYS ASN ILE THR ASP ASP MET TYR LYS LEU VAL ARG ASP SEQRES 26 B 534 GLY LYS TYR ALA SER VAL PRO VAL ILE ILE GLY ASP GLN SEQRES 27 B 534 ASN ASP GLU GLY THR VAL PHE GLY LEU SER SER LEU ASN SEQRES 28 B 534 VAL THR THR ASN ALA GLN ALA ARG ALA TYR PHE LYS GLN SEQRES 29 B 534 SER PHE ILE HIS ALA SER ASP ALA GLU ILE ASP THR LEU SEQRES 30 B 534 MET ALA ALA TYR PRO GLN ASP ILE THR GLN GLY SER PRO SEQRES 31 B 534 PHE ASP THR GLY ILE PHE ASN ALA ILE THR PRO GLN PHE SEQRES 32 B 534 LYS ARG ILE SER ALA VAL LEU GLY ASP LEU ALA PHE ILE SEQRES 33 B 534 HIS ALA ARG ARG TYR PHE LEU ASN HIS PHE GLN GLY GLY SEQRES 34 B 534 THR LYS TYR SER PHE LEU SER LYS GLN LEU SER GLY LEU SEQRES 35 B 534 PRO ILE MET GLY THR PHE HIS ALA ASN ASP ILE VAL TRP SEQRES 36 B 534 GLN ASP TYR LEU LEU GLY SER GLY SER VAL ILE TYR ASN SEQRES 37 B 534 ASN ALA PHE ILE ALA PHE ALA THR ASP LEU ASP PRO ASN SEQRES 38 B 534 THR ALA GLY LEU LEU VAL ASN TRP PRO LYS TYR THR SER SEQRES 39 B 534 SER SER GLN SER GLY ASN ASN LEU MET MET ILE ASN ALA SEQRES 40 B 534 LEU GLY LEU TYR THR GLY LYS ASP ASN PHE ARG THR ALA SEQRES 41 B 534 GLY TYR ASP ALA LEU MET THR ASN PRO SER SER PHE PHE SEQRES 42 B 534 VAL MODRES 1CLE ASN A 314 ASN GLYCOSYLATION SITE MODRES 1CLE ASN A 351 ASN GLYCOSYLATION SITE MODRES 1CLE ASN B 314 ASN GLYCOSYLATION SITE MODRES 1CLE ASN B 351 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG A 535 14 HET PO4 A 601 5 HET CLL A 801 47 HET NAG B 535 14 HET PO4 B 601 5 HET CLL B 802 47 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM PO4 PHOSPHATE ION HETNAM CLL CHOLESTERYL LINOLEATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 6 PO4 2(O4 P 3-) FORMUL 7 CLL 2(C45 H76 O2) FORMUL 11 HOH *478(H2 O) HELIX 1 1 GLY A 34 LEU A 36 5 3 HELIX 2 2 LEU A 73 MET A 82 1 10 HELIX 3 3 LYS A 85 VAL A 90 1 6 HELIX 4 4 PRO A 130 ILE A 132 5 3 HELIX 5 5 ALA A 136 LEU A 144 1 9 HELIX 6 6 ALA A 159 PHE A 163 1 5 HELIX 7 7 ASP A 167 GLU A 172 1 6 HELIX 8 8 ALA A 177 PHE A 196 1 20 HELIX 9 9 SER A 209 GLY A 224 5 16 HELIX 10 10 THR A 253 ALA A 266 1 14 HELIX 11 11 LYS A 274 ARG A 279 1 6 HELIX 12 12 SER A 283 ASN A 292 1 10 HELIX 13 13 MET A 319 ARG A 324 1 6 HELIX 14 14 GLU A 341 THR A 343 5 3 HELIX 15 15 PHE A 345 SER A 349 5 5 HELIX 16 16 ASN A 355 SER A 365 1 11 HELIX 17 17 ASP A 371 ALA A 380 1 10 HELIX 18 18 PHE A 403 ALA A 414 1 12 HELIX 19 19 ILE A 416 HIS A 425 1 10 HELIX 20 20 ASN A 451 ASP A 457 1 7 HELIX 21 21 SER A 462 TYR A 467 5 6 HELIX 22 22 ASN A 469 ASP A 477 1 9 HELIX 23 23 PRO A 480 ALA A 483 5 4 HELIX 24 24 THR A 519 MET A 526 1 8 HELIX 25 25 PRO A 529 PHE A 532 5 4 HELIX 26 26 GLY B 34 LEU B 36 5 3 HELIX 27 27 LEU B 73 GLN B 83 1 11 HELIX 28 28 LYS B 85 VAL B 90 1 6 HELIX 29 29 PRO B 130 ILE B 132 5 3 HELIX 30 30 ALA B 136 LEU B 144 1 9 HELIX 31 31 ALA B 159 PHE B 163 1 5 HELIX 32 32 ASP B 167 GLU B 172 1 6 HELIX 33 33 ALA B 177 PHE B 196 1 20 HELIX 34 34 SER B 209 GLY B 224 5 16 HELIX 35 35 THR B 253 SER B 265 1 13 HELIX 36 36 LYS B 274 LEU B 278 1 5 HELIX 37 37 SER B 283 ASN B 292 1 10 HELIX 38 38 MET B 319 ARG B 324 1 6 HELIX 39 39 THR B 343 SER B 349 1 7 HELIX 40 40 ASN B 355 SER B 365 1 11 HELIX 41 41 ASP B 371 ALA B 380 1 10 HELIX 42 42 ILE B 385 GLN B 387 5 3 HELIX 43 43 PHE B 403 ALA B 414 1 12 HELIX 44 44 ILE B 416 HIS B 425 1 10 HELIX 45 45 ASN B 451 ASP B 457 1 7 HELIX 46 46 SER B 462 TYR B 467 5 6 HELIX 47 47 ASN B 469 ASP B 477 1 9 HELIX 48 48 PRO B 480 ALA B 483 5 4 HELIX 49 49 THR B 519 MET B 526 1 8 HELIX 50 50 PRO B 529 PHE B 532 5 4 SHEET 1 A 2 THR A 3 LYS A 5 0 SHEET 2 A 2 THR A 11 THR A 13 -1 N ILE A 12 O ALA A 4 SHEET 1 B10 ASN A 20 PHE A 23 0 SHEET 2 B10 ILE A 100 PRO A 105 -1 N ARG A 104 O GLU A 21 SHEET 3 B10 ILE A 149 VAL A 154 -1 N ALA A 153 O ASN A 101 SHEET 4 B10 PRO A 115 ILE A 120 1 N PRO A 115 O ILE A 150 SHEET 5 B10 VAL A 203 GLU A 208 1 N THR A 204 O VAL A 116 SHEET 6 B10 ALA A 236 GLN A 240 1 N ALA A 236 O ILE A 205 SHEET 7 B10 PRO A 332 GLN A 338 1 N PRO A 332 O GLY A 237 SHEET 8 B10 LYS A 431 SER A 436 1 N TYR A 432 O VAL A 333 SHEET 9 B10 LEU A 502 ILE A 505 1 N MET A 503 O LEU A 435 SHEET 10 B10 LEU A 510 GLY A 513 -1 N GLY A 513 O LEU A 502 SHEET 1 C 2 THR B 3 LYS B 5 0 SHEET 2 C 2 THR B 11 THR B 13 -1 N ILE B 12 O ALA B 4 SHEET 1 D10 GLU B 21 PHE B 23 0 SHEET 2 D10 ILE B 100 ARG B 104 -1 N ARG B 104 O GLU B 21 SHEET 3 D10 ILE B 149 VAL B 154 -1 N ALA B 153 O ASN B 101 SHEET 4 D10 PRO B 115 ILE B 120 1 N PRO B 115 O ILE B 150 SHEET 5 D10 VAL B 203 GLU B 208 1 N THR B 204 O VAL B 116 SHEET 6 D10 ALA B 236 GLN B 240 1 N ALA B 236 O ILE B 205 SHEET 7 D10 PRO B 332 GLN B 338 1 N PRO B 332 O GLY B 237 SHEET 8 D10 LYS B 431 SER B 436 1 N TYR B 432 O VAL B 333 SHEET 9 D10 LEU B 502 ASN B 506 1 N MET B 503 O LEU B 435 SHEET 10 D10 GLY B 509 GLY B 513 -1 N GLY B 513 O LEU B 502 SSBOND 1 CYS A 60 CYS A 97 1555 1555 2.03 SSBOND 2 CYS A 268 CYS A 277 1555 1555 2.04 SSBOND 3 CYS B 60 CYS B 97 1555 1555 2.03 SSBOND 4 CYS B 268 CYS B 277 1555 1555 2.03 LINK ND2 ASN A 314 C1 NAG A 535 1555 1555 1.46 LINK ND2 ASN A 351 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN B 314 C1 NAG B 535 1555 1555 1.45 LINK ND2 ASN B 351 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.38 CISPEP 1 SER A 389 PRO A 390 0 0.43 CISPEP 2 SER B 389 PRO B 390 0 0.37 SITE 1 CAA 3 SER A 209 GLU A 341 HIS A 449 SITE 1 CAB 3 SER B 209 GLU B 341 HIS B 449 CRYST1 58.790 90.920 58.790 93.39 105.74 97.22 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017010 0.002155 0.005028 0.00000 SCALE2 0.000000 0.011087 0.001088 0.00000 SCALE3 0.000000 0.000000 0.017757 0.00000